These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34750495)

  • 1. D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies.
    Varikasuvu SR; Varshney S; Dutt N; Munikumar M; Asfahan S; Kulkarni PP; Gupta P
    Sci Rep; 2021 Nov; 11(1):21888. PubMed ID: 34750495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.
    Poudel A; Poudel Y; Adhikari A; Aryal BB; Dangol D; Bajracharya T; Maharjan A; Gautam R
    PLoS One; 2021; 16(8):e0256744. PubMed ID: 34437642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Rostami M; Khoshnegah Z; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression.
    Zinellu A; Paliogiannis P; Carru C; Mangoni AA
    Adv Med Sci; 2021 Sep; 66(2):372-380. PubMed ID: 34315012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.
    Sakka M; Connors JM; Hékimian G; Martin-Toutain I; Crichi B; Colmegna I; Bonnefont-Rousselot D; Farge D; Frere C
    J Med Vasc; 2020 Sep; 45(5):268-274. PubMed ID: 32862984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
    Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.
    Cheng A; Hu L; Wang Y; Huang L; Zhao L; Zhang C; Liu X; Xu R; Liu F; Li J; Ye D; Wang T; Lv Y; Liu Q
    Int J Antimicrob Agents; 2020 Sep; 56(3):106110. PubMed ID: 32712332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis.
    Düz ME; Balcı A; Menekşe E
    Tuberk Toraks; 2020 Dec; 68(4):353-360. PubMed ID: 33448732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer level is associated with the severity of COVID-19.
    Yu HH; Qin C; Chen M; Wang W; Tian DS
    Thromb Res; 2020 Nov; 195():219-225. PubMed ID: 32777639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of D-dimer in patients with COVID-19: prognosis value.
    Oualim S; Abdeladim S; Ouarradi AE; Bensahi I; Hafid S; Naitlho A; Bouaiti E; Sabry M
    Pan Afr Med J; 2020; 35(Suppl 2):105. PubMed ID: 33282060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.
    Short SAP; Gupta S; Brenner SK; Hayek SS; Srivastava A; Shaefi S; Singh H; Wu B; Bagchi A; Al-Samkari H; Dy R; Wilkinson K; Zakai NA; Leaf DE;
    Crit Care Med; 2021 May; 49(5):e500-e511. PubMed ID: 33591017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
    Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
    Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
    Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
    [No Abstract]   [Full Text] [Related]  

  • 19. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.